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works of active contours (e.g. snakes, level-sets) or graph-cuts can 
also be applied to segment cells with positive results. Nonetheless, 
these algorithms present high computational complexity.
The main goal of this work was to develop an image processing tool 
using several algorithms in order to improve cell segmentation pro-
cessing for diﬀerent morphological cells and densities. For that pur-
pose, diﬀerent cells were used ‒ MDA-MB-231 and -435, both 
cancer cell lines, and MCF-10-2A, a non-tumorigenic line. Cells were 
observed in a Leica DM IL inverted contrasting microscope, in 
phase-contrast at 100x total magniﬁcation, coupled with a Leica 
D-LUX 3 camera, ensuring the same acquisition conditions. Despite 
the variability in their morphology, preliminary results demonstrated 
that the segmentation process was fairly successfully. As a result, the 
previously described ﬂaws were minimized, leading to more eﬃcient 
animal cell culturing with less variability.
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Abstract
During the past two decades cancer biology knowledge has widely 
increased and shifted the paradigm of cancer treatment from nonspe-
ciﬁc cytotoxic agents to selective, mechanism-based therapeutics. 
Initially, cancer drug design was focused on compounds that rapidly 
killed dividing cells. Though still used as the backbone of current treat-
ments, these highly unspeciﬁc targeting drugs lead to signiﬁcant 
toxicity for patients, narrowing the therapeutic index, and frequently 
lead to drug resistance. Therefore, cancer therapies are now based on 
cancer immunotherapy and targeted agents, whereas novel treat-
ments are strategically combining both to improve clinical outcomes.
Despite the nanotechnology advances dictating the development of 
targeted therapies in diverse classes of nano-based carriers, 
virus-based vectors still remain highly used due to its biocompatibility 
and speciﬁcity for the target.
Particularly, bacteriophages are an interesting alternative ‘nanomedi-
cine’ that can combine biological and chemical components into the 
same drug delivery system. The great potential of this novel platform 
for cancer therapy is the ability to genetically manipulate the virus-vec-
tor to display speciﬁc targeting moieties.
Phage display technology, a general technique used for detecting 
interfaces of various types of interacting proteins outside of the immu-
nological context, allows the target agents to locate the target (with an 
increased selection process for the speciﬁc binding‒ termed biopan-
ning) and play their essential role inhibiting molecular pathways crucial 
for tumour growth and maintenance. Phage display speciﬁcity core is 
related with the binding of small peptides displayed at their coat or 
capsid proteins, enriched during biopanning. Bioinformatics plays an 
important role in testing and improving phage display libraries by 
eﬀective epitope mapping, selecting from a large set of random pep-
tides those with a high binding aﬃnity to a target of interest.
In this work we demonstrate the screening of a manually constructed 
7-mer peptide library of M13KE phage particles against 
MDA-MB-231 and -435 cancer cell lines. Two peptides ‒ TLATVEV 
and PRLNVSP ‒ with high aﬃnity for the referred cells were identiﬁed, 
respectively. Based on computationally predicted epitopes based on 
the peptides extracted from this library the linear peptide sequence 
was docked onto known membrane proteins from the used cell lines 
and peptides-proteins interactions were mapped. Umbrella sampling 
studies were performed to predict the binding aﬃnity and to improve 
future rational design of binding peptides to these cancer cells.
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